User menu

Population Monitoring for Genetic-damage Induced By Environmental Physical and Chemical-agents

Bibliographic reference Leonard, A. ; Duvergervanbogaert, M. ; Bernard, Alfred ; Lambottevandepaer, M. ; Lauwerys, Robert. Population Monitoring for Genetic-damage Induced By Environmental Physical and Chemical-agents. In: Environmental Monitoring and Assessment : an international journal devoted to progress in the use of monitoring data in assessing environmental risks to man and the environment, Vol. 5, no. 4, p. 369-384 (1985)
Permanent URL
  1. Abe, T., Isemura, T., and Kikuchi, Y.: 1984, ?Micronuclei in Human Bone-marrow cells Evaluation of the Micronucleus Test Using Leukemia Patients Treated with Antileukemic Agents?, Mutation Res. 130, 113?120.
  2. Andersson, H. A., Synder, J., Lewinson, T., Woo, C., Lilis, R., and Selikoff, I. J.: 1978, ?Levels of CEA among Vinyl Chloride and Polyvinylchloride Exposed Workers?, Cancer 42, 1560?1567.
  3. Albertini, R. J.: 1979, ?Direct mutagenicity testing with peripheral blood lymphocytes?, in A. W. Hsie, J. P. O'Neill, and V. K. McEhlency, (eds.), Mammalian Cell Mutagenesis: The Maturation of Test Systems. Brandbury Report 2, Cold Spring Harbor Laboratory, pp. 359?373.
  4. Albertini, R. J.: 1980, ?Drug Resistant Lymphocytes in Man as Indicators of Somatic Cell Mutation?, Teratog. Carcinog. Mutagen. 1, 25?48.
  5. Albertini, R. J., Sylwester, D. L., and Allen, E. F.: 1982, ?The 6-Thioguanine-Resistant Peripheral Blood Lymphocyte Assay for Direct Mutagenicity Testing in Humans?, in J. A. Heddle (ed.), Mutagenicity. New Horizons in Genetic Toxicology, Academic Press, pp. 305?336.
  6. Amacher, D. E., Turner, G. N., and Ellis, J. H.: 1981, ?Detection of Mammalian Cell Mutagens in Urine from Carcinogen Dosed Mice?, Mutation Res 90, 79?90.
  7. Ames, B. N., McCann, J., and Yamasaki, E.: 1975, ?Methods for Detecting Carcinogens and Mutagens with the Salmonella/mammalian Microsome Mutagenicity Test?, Mutation Res. 31, 347?364.
  8. Bailey, E., Connors, T. A., Farmer, P. B., Gorf, S. M., and Richard, J.: 1981, ?Methylation of Cysteine in Hemoglobin Following Exposure to Methylating Agents?, Cancer Res. 41, 2514?1517.
  9. Bigbee, W. L., Branscomb, E. W., and Jensen, R. H.: 1982, ?Detection of Mutated Erythrocytes in Man, American-Swedish Workshop on Individual Susceptibility to Genotoxic Agents in the Human Population?, NIEHS, Research Triangle Park, N.C. (in press).
  10. Blum, A., Gold, M. D., Ames, B. N., Kenyon, C., Jones, F. R., Hett, E. A., Dougherty, R. C., Horning, E., Dzidic, I., Carroll, D. I., Stillwell, R. N., and Thenot, J. P.: 1978, ?Children Absorb Tris-BP Flame Retardant from Sleepwear: Urine Contains the Mutagenic Metabolite, 2,3-Dibromopropanol?, Science 201, 1020?1023.
  11. Brewen, J. G. and Stetka, D. G.: 1982, ?Cytogenetic Events in vivo?, in J. A. Heddle (ed.), Mutagenicity, New Horizons in Genetic Toxicology, Academic Press, pp. 351?384.
  12. Bridges, J. W. and Hubbard, S. A.: 1980, ?Problems in Providing an Appropriate Drug Metabolising System for Short-Term Tests for Carcinogens?, in G. M. Williams, R. Kroes, H. W. Wasijers, and K. W. van de Pol (eds.), The Predictive Value of Short-Term Screening Tests in Carcinogenicity Evaluation, Elsevier North Holland Biomedical Press, pp. 69?88.
  13. Bruce, W. R., Varhese, A. J., Furrer, R., and Land, P. C.: 1977, ?A Mutagen in the Feces of Normal Humans?, in H. H. Hiatt, J. D. Watson, and J. A. Winsten (eds.), Origins of Human Cancer, Cold Spring Harbor Laboratory Press, New-York, pp. 1641?1646.
  14. Buckton, K. E., Court-Brown, W. M., and Smith, P. G.: 1982, ?Lymphocyte Survival in Men Treated with X-rays for Ankylosing Spondylitis?, Nature (London) 214, 470?473.
  15. Calleman, C. J., Ehrenberg, L., Janson, B., Osterman-Golkar, S., Segerback, D., Svensson, R., and Wachtmeister, C. A.: 1978, ?Monitoring and Risk Assessment by Means of Alkyl Groups in Hemoglobin in Persons Occupationally Exposed to Ethylene Oxide?, J. Environ. Pathol. Toxicol. 2, 427?442.
  16. Carrano, A. V. and Moore, D. H.: 1982, ?The Rational and Methodology for Quantifying Sister Chromatid Exchange in Humans?, in J. A. Heddle (ed.), Mutagenicity, New Horizons in Genetic Toxicology, Academic Press, pp. 267?304.
  17. Clive, D.: 1981, ?Comparative Chemical Mutagenicity: Can we Make Risk Estimates??, in F. J. de Serres and M. D. Shelby (eds.), Comparative Chemical Mutagenesis, Plenum Press, pp. 1039?1066.
  18. Congress of the United States: 1982, ?The Role of Genetic Testing in the Prevention of Occupational Disease?, Office of Technology Assessment, Washington DC, p. 27.
  19. de Serres, F. J.: 1983, ?Assessment of the International Programme for the Evaluation of Short-Term Tests for Carcinogenicity?, in S. Garattini, G. Mazué, R. Roncucci, and G. M. Williams (eds.), Short-Term tests for Carcinogenesis, Montpelier 4?5 février 1981, Centre de Recherche Clin Midy-Groupe SANOFI, pp. 330?339.
  20. de Serres, F. J.: 1984, ?Population Monitoring: Methods and Applications?, Mutation Res. 130, 73?77.
  21. Dolphin, G. W., Lloyd, D. C., and Purrott, R. J.: 1973, ?Chromosome Aberration Analysis as a Dosimetric Technique in Radiological Protection?, Health Physics 25, 7?15.
  22. Ehrich, M., Aswell, J. E., Van Tassell, R. L., and Wilkins, T. D.: 1979, ?Mutagens in the Feces of 3 South-African Populations at Different Levels of Risk for Colon Cancer?, Mutation Res. 64, 231?240.
  23. Falck, K., Gröhn, P., Sorsa, M., Vainio, H., and Heinonen, E.: 1979, ?Mutagenicity in Urine of Nurses Handling Cytostatic Drugs?, Lancet 1250?1251.
  24. Falck, K., Sorsa, M., Vainio, H., and Kilpikari, L.: 1980, ?Mutagenicity in Urine Workers in Rubber Industry?, Mutation Res. 79, 45?52.
  25. Forni, A.: 1983, ?Chromosome Aberrations in Monitoring Exposures to Mutagens-Carcinogens?, International seminar on methods of monitoring human exposure to carcinogenic and mutagenic agents, 12?15 December 1983, Espoo, Finland.
  26. Gabridge, M. G., Denunzio, A., and Legator, M. S.: 1969, ?Microbial Mutagenicity of Streptozotocin in Animal Mediated Assays?, Nature 221, 68?70.
  27. Goetz, P., Sram, R. J., and Dohnalova, J.: 1975, ?Relationship Between Experimental Results and Man, I. Cytogenetic Analysis of Bone Marrow Injury by a Single Dose of Cyclophosphamide?, Mutation Res. 31, 247?254.
  28. Goetz, P., Sram, R. J., Kodytkkova, I., Dohnalova, J., Dostalova, O., and Bartova, J.: 1976, ?Relationship Between Experimental Results in Mammals and Man, II. Cytogenetic Analysis of Bone Marrow cells after Treatment of Cytembena and Cyclophosphamide-Cytembena combination?, Mutation Res. 41, 143?152.
  29. Green, M. H. L. and Muriel, W. J.: 1976, ?Mutagen Testing Using TRP+ Versions in Escherichia coli?, Mutation Res. 38, 3?32.
  30. Green, M. H. L., Rogers, A. M., Muriel, W. J., Ward, A. C., and McCalla, D. R.: 1977, ?Use of a Simplified Fluctuation Test to Detect and Characterise Mutagenesis by Nitrofurans?, Mutation Res. 44, 139?143.
  31. Hacker, U., Schumann, U., and Göhde, W.: 1982, ?Mammalian Spermatogenesis as a New System for Biologic Dosimetry of Ionizing Radiation?, Acta Radiologica Oncology 21, 349?351.
  32. Hansteen, I. L.: 1982, ?SCE as a Monitor of Industrial and Environmental Toxins?, in A. A. Sandberg (ed.), Sister Chromatid Exchange, Alan R. Liss, Inc., New York, pp. 657?697.
  33. Hayatsu, H. S., Arimoto, K., Togawa, K., and Makita, M.: 1981, ?Inhibitory Effect of the Ether Extract of Human Feces on Activities of Mutagens; Inhibition by Oleic and Linoleic Acids?, Mutation Res. 81, 287?293.
  34. Heddle, J. A., Blakey, D. H., Duncan, A. M. V., Goldberg, M. T., Newmlark, H., Wargovich, M. J., and Bruce, W. R.: 1982, ?Micronuclei and Related Nuclear Anomalies as a Short-Term Assay for Colon Carcinogenesis?, in B. A. Bridges, B. E. Butterworth, and I. B. Weinstein (eds.), Banbury Report 13, Cold Spring Harbor Laboratory, pp. 367?377.
  35. Högstedt, B., Gullberg, B., Mark-Vendel, E., Mitelman, F., and Skerfving, S.: 1981a, ?Micronuclei in Erythropoietic Bone Marrow Cells: Relation to Cytogenetic Pattern and Prognosis in Acute Nonlymphocytic eukemia?, Cancer Genet. Cytogenet. 3, 185?193.
  36. Högstedt, B., Gullberg, B., Mark-Vendel, E., Mitelman, F., and Skerfving, S.: 1981b, ?Micronuclei and Chromosome Aberrations in Bone Marrow Cells and Lymphocytes of Humans Exposed Mainly to Petroleum Vapors?, Herditas 94, 179?187.
  37. Hollstein, M., McCann, J., Angelosanto, F. A., and Nichols, W. W.: 1979, ?Short-Term Tests for Carcinogens and Mutagens?, Mutation Res. 65, 133?226.
  38. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: 1980, Some Non-Nutritive Sweeting Agents 22, 55?170.
  39. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: 1982, Suppl. 4, 208?211.
  40. Jacobs, M.: 1979, ?A Critical Review: Will the Ames Salmonella Assay System be Used as a Screen for Presumptive Carcinogens??, J. Environ. Pathol. Toxicol. 2, 1205?1215.
  41. Kapp, R. W. and Jacobson, C. B.: 1980, ?Analysis of Human Spermatozoa for Y Chromosomal Non Disjunction?, Teratogen-carcinogen. Mutagenesis 1, 193?211.
  42. Kapp Robert W., Picciano Dante J., Jacobson Cecil B., Y-chromosomal nondisjunction in dibromochloropropane-exposed workmen, 10.1016/0165-1161(79)90136-5
  43. Karube, I., Matsunage, T., Nakahara, T., Suzuki, S., and Kada, T.: 1981, ?Preliminary Screening of Mutagens with a Microbial Sensor?, Anal. Chem. 53, 1024?1026.
  44. Kilpikari, I.: 1981, ?Correlation of Urinary Thioethers with Chemical Exposure in a Rubber Plant?, Brit. J. Ind. Med. 38, 98?102.
  45. Kucerova, M.: 1982, ?Chromosomal Aberrations Induced in Occupationally Exposed Persons?, in J. A. Heddle (ed.), Mutagenicity, New Horizons in Genetic Toxicology, Academic Press, pp. 241?266.
  46. Kuhnlein Urs, Bergstrom Danielle, Kuhnlein Harriet, Mutagens in feces from vegetarians and non-vegetarians, 10.1016/0165-1161(81)90281-8
  47. Kumar, S., Wilson, P., Brenchley, P., Taylor, G., Bjorklund, B., and Eklund, G.: 1978, ?Frequent Elevation of Tissue Polypeptide Antigen in the Sera of Workers Exposed to Bladder Carcinogens?, Int. J. Cancer 22, 542?545.
  48. Lauwerys, R.: 1983, ?Industrial Chemical Monitoring: Guidelines for Biological Monitoring?, Biomedical Publications, Davis, CA.
  49. Legator, M. S., Connor, T. H., and Stoeckel, M.: 1975a, ?Detection of Mutagenic Activity of Metronidazole and Niridazole in Body Fluids of Humans and Mice?, Science 188, 1118?1119.
  50. Legator, M. S., Connor, T. H., and Stoeckel, M.: 1975b, ?The Detection of Mutagenic Substances in the Urine and Blood of Man?, Ann. N.Y. Acad. Sci. 269, 16?20.
  51. Legator, M. S., Pullin, T. G., and Connor, T. H.: 1977, ?The Isolation and Detection of Mutagenic Substances in Body Fluid and Tissues of Animals and Body Fluid of Human Subjects?, in B. J. Kilbey, M. Legator, W. Nichols, and C. Ramel (eds.), Handbook of Mutagenicity Test Procedures, Elsevier S.P.C., pp. 149?159.
  52. Léonard, A.: 1981, ?Cytogenetic Test to Assess Carcinogenic Properties of Chemicals?, in S. Garattini, G. Mazué, R. Roncucci, and G. M. Williams (eds.), Short-Term Tests for Carcinogenesis, Montpellier 4?5 février 1981, Centre de Recherches Clin Midy-Groupe SANOFI, pp. 280?288.
  53. Léonard, A.: 1983, ?Anomalies chromosomiques produites par exposition aux agents clastogènes physiques et chimiques présents dans notre environnement?, Journée d'Etude sur les Caryotypes, EDF Paris 10 mai 1983, pp. 38?46.
  54. Lohman, P. H. M., Jansen, J. D., and Baan, R. A.: 1984, ?Comparison of Various Methodologies with Respect to Specificity and Sensitivity in Biomonitoring Occupational Exposure to Mutagens and Carcinogens?, Int. Seminar on Methods of Monitoring Human Exposure to Carcinogenic and Mutagenic Agents, December 12?15, 1983, Espoo, Finland (in press).
  55. Lofroth, G., Osterman-Golkar, S., and Weinerberg, R.: 1974, ?Urinary Excretion of Methylated Purines Following Inhalation of Dimethylsulfate?, Experientia 15, 641?642.
  56. Lofroth, G. and Weinerberg, R.: 1974, ?Mythylation of Purines and Nicotinamide in the Rat by Dichlorovs?, Z. Naturforsch. 29, 651.
  57. Loprieno, N.: 1981, ?Short Term Tests to Assess the Mutagenic and Carcinogenic Hazards of New Chemicals?, Biol. Internat. 3, 1?14.
  58. Maron Dorothy M., Ames Bruce N., Revised methods for the Salmonella mutagenicity test, 10.1016/0165-1161(83)90010-9
  59. Montesano, R., Rajewsky, M. F., Pegg, A. E., and Miller, E.: 1982, ?Development and Possible Use of Immunological Techniques to Detect Individual Exposure to Carcinogens?, IARC/IPCS Working Group Report, Cancer Res. 42, 5236?5239.
  60. Natarajan, A. T. and Obe, G.: 1982, ?Mutagenicity Testing with Cultured Mammalian Cells: Cytogenetic Assays?, in J. A. Heddle (ed.), Mutagenicity, New Horizons in Genetic Toxicology, Academic Press, pp. 171?213.
  61. Neumann, H. G.: 1984, ?Analysis of Hemoglobin as a Dose Monitor for Alkylating and Arylating Agents?, Arch. Toxicol. 56, 1?6.
  62. Nordenson, I., Beckman, L., Liden, S., and Stjernberg, N.: 1984, ?Chromosomal Aberrations and Cancer Risk?, Hum. Hered. 34, 76?81.
  63. Obe, G. and Beek, B.: 1982, ?The Human Leukocyte System?, in F. J. de Serres and A. Hollaender (eds.), Chemical Mutagens, Principles and Methods for their Detection, Plenum Press, Vol. 7, pp. 337?340.
  64. Osterman-Golkar S., Ehrenberg L., Segerbäck D., Hällström I., Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor, 10.1016/0027-5107(76)90256-6
  65. Petrakis, N. L., Maack, C. A., Lee, R. E., and Lyon, M.: 1980, ?Mutagenic Activity in Nipple Aspirates of Human Breast Fluid?, Letter to the Editor, Cancer Res. 40, 188?189.
  66. Petrakis, N. L., Gruenke, L. D., and Craig, J. C.: 1981, ?Cholesterol and Cholesterol Epoxides in Nipple Aspirates of Human Breast Fluid?, Cancer Res. 41, 2563?2566.
  67. Pious, D. and Soderland, C.: 1977, ?HLA Variants of Cultured Human Lymphoid Cells: Evidence for Mutational Original and Estimation of Mutation Rate?, Science 197, 769?771.
  68. Rall, D. P.: 1977, ?Species Differences in Carcinogenesis Testing?, in Hiatt, Watson, and Winster (eds.), Origins of Human Cancer. Book C., Cold Spring Harbor Laboratory, 1383?1390.
  69. Salvatore, F., Colonna, A., Costanzo, F., Russo, T., Esposito, F., and Cimino, F.: 1983, ?Modified Nucleosides in Body Fluids of Tumor Bearning Patients?, in G. Nass (ed.), Recent Results in Cancer Research, Springer-Verlag, New York, pp. 360?377.
  70. Schmid W., The Micronucleus Test for Cytogenetic Analysis, Chemical Mutagens (1976) ISBN:9781468408942 p.31-53, 10.1007/978-1-4684-0892-8_2
  71. Sergerback, D. A.: 1983, ?Alkylation of DNA and Haemoglobin in the Mouse Following Exposure to Ethylene and Ethylene Oxide?, Chem. Biol. Interactions 45, 139?151.
  72. Seutter-Berlage, F., Van Dorp, H. L., Kosse, H. G. T., and Henderson, P. T.: 1977, ?Urinary Mercapturic Acid Excretion as a Biological Parameter of Exposure to Alkylating Agents?, Int. Arch. Occup. Environ. Health 39, 45?51.
  73. Siebert D., Simon Ursula, Cyclophosphamide: Pilot study of genetically active metabolites in the urine of a treated human patient induction of mitotic gene conversions in yeast, 10.1016/0027-5107(73)90114-0
  74. Sobels, F. H.: 1981, ?Establishment of Requirements for Estimation of Risk for the Human Population?, in F. J. de Serres and M. D. Shelby (eds.), Comparative Chemical Mutagenesis, Plenum Press, pp. 1067?1101.
  75. Sorsa, M., Falck, K., Norppa, H., and Vainio, H.: 1981, ?Monitoring Genotoxicity in the Occupational Environment?, Scand. J. Work. Environ. Health 7, suppl. 4, 61?65.
  76. Sorsa Marja, Falck Kai, Maki-Paakkanen J, Vainio Harri, Genotoxic hazards in the rubber industry., 10.5271/sjweh.2437
  77. Stamatoyannopoulos, G.: 1979, ?Possibilities for Demonstrating Point Mutations in Somatic Cells, as Illustrated by Mutant Hemoglobins?, in K. Berg (ed.), Genetic Damage in Man Caused by Environmental Agents, Academic Press, New York, pp. 49?62.
  78. Stamatoyannopoulos, G., Nute, P. E., Papayannopoulos, Th. McGuira, T., Lim, G., Bunn, H. F., and Rucknagel, D.: 1980, ?Development of a Somatic Mutation Screening System Using Hb Mutants, IV. Successful Detection of red Cells Containing the Human Frameshift Mutants Hb Wayne and Hb Cranston Using Monospecific Fluorescent Antibodies?, Ann. J. Hum. Genet. 32, 484?496.
  79. Stetka, D. G.: 1982, ?Operative and Non-Operative Mechanism of Sister Chromatid Exchange?, in A. A. Sandberg (ed.), Sister Chromatid Exchange, Alan Liss Inc., New York, pp. 99?144.
  80. Strauss, G. H. and Albertini, R. J.: 1977, ?6-Thioguanine Resistant Lymphocytes in Human Peripheral Blood?, in D. Scott, B. A. Bridges, and F. H. Sobels (eds.), Progress in Genetic Toxicology, Elsevier, pp. 327?336.
  81. Strauss Gary H., Albertini Richard J., Enumeration of 6-thioguanine-resistant peripheral blood lymphocytes in man as a potential test for somatic cell mutations arising in vivo, 10.1016/0027-5107(79)90140-4
  82. Streisinger George, ICPEMC working paper 4/2 extrapolations from species to species and from various cell types in assessing risks from chemical mutagens, 10.1016/0165-1110(83)90021-0
  83. Thilly W. G., DeLuca J. G., Furth E. E., Hoppe H., Kaden D. A., Krolewski J. J., Liber H. L., Skopek T. R., Slapikoff S. A., Tizard R. J., Penman B. W., Gene-Locus Mutation Assays in Diploid Human Lymphoblast Lines, Chemical Mutagens (1980) ISBN:9781461330745 p.331-364, 10.1007/978-1-4613-3072-1_12
  84. Trepel, F.: 1976, ?Das lymphatische Zellsystem: Struktur, allgemeine Physiologie und allgemeine Pathophysiologie?, in H. Begeman (ed.), Blut and Blutkrankheiten, Teil 3, Leukocytäres und retikuläres System, Springer-Verlag, pp. 1?191.
  85. Vainio, H., Savolainen, H., and Kilpari, I.: 1978, ?Urinary Thioether of Employees of a Chemical Plant?, Brit. J. Ind. Med. 35, 232?234.
  86. Vainio Harri, Sorsa Marja, Rantanen Jorma, Hemminki Kari, Aitio Antero, Biological monitoring in the identification of the cancer of individuals exposed to chemical carcinogens., 10.5271/sjweh.2552
  87. Varhese, A. J. P., Land, R., Furrer, R., and Bruce, W. R.: 1977, ?N-nitroso Compounds in the Human Body?, Proc. Am. Ass. Cancer Res. 18, 80.
  88. Venitt S., Mutagens in human faeces, 10.1016/0165-1110(82)90036-7
  89. Würgler, F. E., Sobels, F. H., and Vogel, E.: 1977, ?Drosophila as Assay System for Detecting Genetic Changes?, in B. J. Kilbey, M. Legator, W. Nichols, and C. Ramel (eds.), Handbook of Mutagenicity Procedures, Elsevier, Amsterdam, New York, Oxford, pp. 335?374.
  90. Wyrobek, A. J.: 1981, ?Methods for Human and Murine Sperm Assays?, in H. F. Stich and R. M. C. San (eds.), Short-Term Tests for Chemical Carcinogens, Springer-Verlag, pp. 408?419.
  91. Wyrobek, A. J.: 1982, ?Sperm Assays as Indicators of Chemically Induced Germ-Cell Damage in Man?, in J. A. Heddle (ed.), Mutagenicity, New Horizons in Genetic Toxicology, Academic Press, pp. 337?350.
  92. Wyrobek, A. J., Burkhart, J. G., Francis, M. C., Gordon, L. Kapp, R. W., Letz, G., Malling, H. V., Topham, J. G., and Whorton, M. D.: 1982, ?Chemically Induced Alterations of Spermatogenic Function in Man as Measured by Semen Analysis Parameters: A Report for the Genotox Program?, Mutation Res.
  93. Yamasaki, E. and Ames, B. N.: 1977, ?Concentration of Mutagens from Urine by Adsorption with the Non Polar Resin XAD-2: Cigarette Smokers Have Mutagenic Urine?, Proc. Natl. Acad. Sci. U.S.A., Vol. 74, No. 8, 3555?3559.
  94. Zimmering, S.: 1975, ?Utility of Drosophile for Detection of Potential Environmental Chemical Mutagens?, Ann. N.Y.-Acad. Sci. 269, 26?33.
  95. Zimmermann, F. K.: 1977, ?Procedures Used in the Induction of Mitotic Recombination and Mutation in the Yeast Saccharomyces Cerevisiae? in B. J. Kilby, M. Legator, W. Nichols, and C. Ramel, (eds.), Handbook of Mutagenicity Procedures, Elsevier, Amsterdam, New York, Oxford, pp. 119?134.